Stock CHHE CHINA HEALTH INDUSTRIES HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials China Health Industries Holdings, Inc.

Equities

CHHE

US1693981045

Pharmaceuticals

Market Closed - OTC Markets
Other stock markets
 12:55:49 2024-05-30 pm EDT 		5-day change 1st Jan Change
0.9899 USD +41.41% Intraday chart for China Health Industries Holdings, Inc. +16.46% +103.06%
Apr. 01 China Health Industries Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
2023 China Health Industries Holdings, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023 CI

Valuation

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Capitalization 1 60.3 49.15 22.94 13.28 0.7013 14.66
Enterprise Value (EV) 1 34.08 20.61 -5.874 -22.98 -37.33 19.77
P/E ratio -190 x 14.9 x 6.46 x 10.3 x -1.98 x -35.9 x
Yield - - - - - -
Capitalization / Revenue 9.2 x 5.3 x 2.31 x 2.05 x 2,626 x 131 x
EV / Revenue 5.2 x 2.22 x -0.59 x -3.54 x -139,809 x 177 x
EV / EBITDA 169 x 3.83 x -1.03 x -8.38 x 45.7 x -17.1 x
EV / FCF 39.2 x 6.9 x -10.1 x -5.62 x -14.8 x -0.48 x
FCF Yield 2.55% 14.5% -9.91% -17.8% -6.77% -207%
Price to Book 1.71 x 1.32 x 0.58 x 0.3 x 0.02 x 0.37 x
Nbr of stocks (in thousands) 65,540 65,540 65,540 65,540 65,540 65,540
Reference price 2 0.9200 0.7500 0.3500 0.2027 0.0107 0.2237
Announcement Date 9/28/18 9/11/19 10/13/20 9/20/21 9/15/22 11/13/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales 1 6.555 9.275 9.932 6.493 0.000267 0.1116
EBITDA 1 0.2019 5.38 5.697 2.743 -0.8174 -1.156
EBIT 1 -0.4669 4.562 4.892 1.864 -1.648 -1.843
Operating Margin -7.12% 49.18% 49.26% 28.71% -617,199.63% -1,651.39%
Earnings before Tax (EBT) 1 -0.0538 4.691 5.017 2.022 -0.351 -0.4088
Net income 1 -0.3168 3.307 3.551 1.291 -0.354 -0.4088
Net margin -4.83% 35.65% 35.75% 19.89% -132,565.54% -366.35%
EPS 2 -0.004834 0.0505 0.0542 0.0197 -0.005400 -0.006237
Free Cash Flow 1 0.8696 2.987 0.5823 4.09 2.529 -40.95
FCF margin 13.27% 32.2% 5.86% 63% 947,015.73% -36,697.59%
FCF Conversion (EBITDA) 430.75% 55.52% 10.22% 149.13% - -
FCF Conversion (Net income) - 90.31% 16.4% 316.79% - -
Dividend per Share - - - - - -
Announcement Date 9/28/18 9/11/19 10/13/20 9/20/21 9/15/22 11/13/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - 5.11
Net Cash position 1 26.2 28.5 28.8 36.3 38 -
Leverage (Debt/EBITDA) - - - - - -4.418 x
Free Cash Flow 1 0.87 2.99 0.58 4.09 2.53 -40.9
ROE (net income / shareholders' equity) -0.91% 9.13% 9.24% 3.06% -0.81% -1%
ROA (Net income/ Total Assets) -0.69% 6.43% 6.51% 2.28% -1.97% -2.4%
Assets 1 45.95 51.43 54.57 56.59 17.98 17.01
Book Value Per Share 2 0.5400 0.5700 0.6100 0.6800 0.6500 0.6000
Cash Flow per Share 2 0.5000 0.5400 0.5500 0.6800 0.6800 0
Capex 1 0.41 0.15 0.16 0.01 - -
Capex / Sales 6.21% 1.66% 1.59% 0.21% - -
Announcement Date 9/28/18 9/11/19 10/13/20 9/20/21 9/15/22 11/13/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
CHINA HEALTH INDUSTRIES HOLDINGS, INC. Stock China Health Industries Holdings, Inc.
+103.06% 64.88M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+40.73% 739B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.83% 598B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.30% 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.15% 318B
ABBVIE INC. Stock AbbVie Inc.
+4.05% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.00% 240B
NOVARTIS AG Stock Novartis AG
+9.78% 210B
ROCHE HOLDING AG Stock Roche Holding AG
-5.52% 206B
AMGEN INC. Stock Amgen Inc.
+6.17% 164B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. CHHE Stock
  4. Financials China Health Industries Holdings, Inc.